Global Duplex Sequencing Market by Offering (Software and Tools, Duplex Sequencing Kits, Assays and Reagents, and Others); By Application (Genomics, Cancer Research, Forensics, Virology, and Others); By End-User (Clinics and Laboratories, Hospitals, Academic Institutions and Research Centers, Government Forensic Departments, and Others); By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia(Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia) Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2021 – 2029
Industry Trends
Duplex sequencing plays an important role in forensic studies and cancer diagnosis. Hence, increasing occurrence of cancer and genetic diagnosis method is expected to fuel the growth of the duplex sequencing market. In addition to this, significant growth in development of medical infrastructure along with the technological advancements in the field of duplex sequencing is projected to drive growth of the global duplex sequencing market. On the other hand, supportive government policies for product development and molecular research is projected to further boost this growth. However, a number of factors such as lack of reimbursement, and high cost associated with duplex sequencing procedure is likely to hamper the growth of the market to some extent during the forecast period. On the contrary, use of AI in duplex sequencing is opportunistic for growth of this market.
Duplex sequencing refers to the preparation of a library for the analysis of next generation sequencing (NGS) techniques that utilize double strands DNA for the detection of mutations with a higher degree of accuracy and precision, with considerably fewer errors. With the use of duplex sequencing, the detection of mutations in frequencies in the range of 5 x 10−8 is possible, based on theoretical studies, and makes it about 10,000 times greater in accuracy as compared to conventional sequencing models which are being used at present. Furthermore, this method of sequencing is compatible with all illumina sequencer, and it is can be adopted easily without the need for specialized equipment to handle load. Duplex sequencing has the ability to eliminate background noise, which in turn helps in detecting mutations which were earlier hidden. The COVID-19 has caused a highly transmissible and ongoing pandemic across the globe. However, this has led to the rise in concern over fast spreading, novel variants of the SARS-CoV-2 coronavirus, such as the Delta and Omicron strains, highlighting the need for sequencing to detect mutations quickly as well as to prevent spread of the new strains. Hence, need for next-generation sequencing during the COVID-19 pandemic provides an effective way to identify new coronavirus strains and other pathogens, which is estimated to drive the duplex sequencing market.
The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Global Duplex Sequencing Market Revenue & Forecast, (US$ Million), 2021 – 2029
Offerings Outlook:
Based on offerings, duplex sequencing market has been segmented into software and tools, duplex sequencing kits, assays and reagents, and others. Duplex sequencing kits followed by software and tools to dominate the duplex sequencing market in 2020. The growth of the duplex sequencing kits segment can be attributed to the wide offerings in the kits which is needed to convert DNA into Duplex Libraries. However, software and tools segment is anticipated to witness highest growth rate during the forecast period.
Application Outlook:
Based on application, the global duplex sequencing market has been segmented into genomics, cancer research, forensics, virology, and others. Cancer research accounted for the highest market share in duplex sequencing market in 2020. The growth in this segment can be attributed to rising prevalence of cancer and rising research trend in cancer treatment industry. For instance, in December 2020, a recent research study published in Proceedings of the National Academy of Sciences (PNAS) found that TwinStrand Biosciences’ Duplex Sequencing Technology characterized and identified ultra-low frequency gene mutations as well as early cancer growth caused by carcinogens in mouse models.
End-User Outlook:
Based on end-user, the global duplex sequencing market has been segmented into clinics and laboratories, hospitals, academic institutions and research centers, government forensic departments, and others. Clinics and laboratories accounted for the highest market share in duplex sequencing market in 2020. Duplex sequencing technology primarily helps to ensure critical decisions in clinical medicine. Further, next generation DNA sequencing (NGS) has the power to revolutionize biology and medicine; thus, fuelling growth of clinics and laboratories.
Region Outlook:
Based on the regions, North America has emerged as the largest regional market in 2020. Growth of this region is mainly driven by rising prevalence of cancer and forensic studies. In addition to this, significant availability of sophisticated research facilities and well-developed healthcare infrastructure in the region is boosting growth of the market. On the other hand, the Europe duplex sequencing market is driven by presence of advanced medical facilities as well as well-developed healthcare infrastructure.
Competitive Landscape
The report provides both, qualitative and quantitative research of global duplex sequencing market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the key players operating in the global duplex sequencing market are:
- ATDBio Ltd
- Illumina, Inc.
- Promega Corporation
- QIAGEN
- Thermo Fisher Scientific
- TwinStrand Biosciences, Inc.
- Other Market Participants
Global Duplex sequencing Market:
By Offering:
- Software and Tools
- Duplex Sequencing Kits
- Assays and Reagents
- Others
By Application:
- Genomics
- Cancer Research
- Forensics
- Virology
- Others
By End-Use Industry:
- Clinics and Laboratories
- Hospitals
- Academic Institutions and Research Centers
- Government Forensic Departments
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1. Market Scope
1.1. Market Segmentation
1.2. Years Considered
1.2.1.
Base Year: 2020
1.2.2. Forecast Years: 2021 – 2029
2. Key Target Audiences
3. Research Methodology
3.1. Primary Research
3.1.1. Research Questionnaire
3.1.2. Global Percentage Breakdown
3.1.3. Primary Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary Research
3.2.1. Paid Databases
3.2.2. Secondary Sources
3.3. Market Size Estimates
3.3.1. Top-Down Approach
3.3.2. Bottom-Up Approach
3.4. Data Triangulation Methodology
3.5. Research Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Duplex Sequencing Market
6. Market Synopsis:
Duplex Sequencing Market
7. Duplex Sequencing Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product Definition
7.1.2. Industry Development
7.2. Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.2.4. Challenges
7.3. Trends in Duplex Sequencing Market
7.4. Market Determinants Radar Chart
7.5. Macro-Economic and Micro-Economic Indicators: Duplex
Sequencing Market
7.6. Impact of Covid-19 on Duplex Sequencing Market
8. Global Duplex Sequencing Market Analysis and Forecasts, 2021
– 2029
8.1. Overview
8.1.1. Global Duplex Sequencing Market Revenue (US$ Mn)
8.2. Global Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Offerings
8.2.1. Software and Tools
8.2.1.1.
Definition
8.2.1.2. Market Estimation and Penetration, 2020
8.2.1.3. Market Forecast, 2021 - 2029
8.2.1.4. Compound Annual Growth Rate (CAGR)
8.2.1.5. Regional Bifurcation
8.2.1.5.1. North America
8.2.1.5.1.1. Market
Estimation, 2020
8.2.1.5.1.2. Market
Forecast, 2021 - 2029
8.2.1.5.2. Europe
8.2.1.5.2.1. Market
Estimation, 2020
8.2.1.5.2.2. Market
Forecast, 2021 - 2029
8.2.1.5.3. Asia Pacific
8.2.1.5.3.1. Market
Estimation, 2020
8.2.1.5.3.2. Market
Forecast, 2021 - 2029
8.2.1.5.4. Middle East and Africa
8.2.1.5.4.1. Market
Estimation, 2020
8.2.1.5.4.2. Market
Forecast, 2021 - 2029
8.2.1.5.5. Latin America
8.2.1.5.5.1. Market
Estimation, 2020
8.2.1.5.5.2. Market
Forecast, 2021 - 2029
8.2.2. Duplex Sequencing Kits
8.2.2.1.
Definition
8.2.2.2. Market Estimation and Penetration, 2020
8.2.2.3. Market Forecast, 2021 - 2029
8.2.2.4. Compound Annual Growth Rate (CAGR)
8.2.2.5. Regional Bifurcation
8.2.2.5.1. North America
8.2.2.5.1.1. Market
Estimation, 2020
8.2.2.5.1.2. Market
Forecast, 2021 - 2029
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation, 2020
8.2.2.5.2.2. Market
Forecast, 2021 - 2029
8.2.2.5.3. Asia Pacific
8.2.2.5.3.1. Market
Estimation, 2020
8.2.2.5.3.2. Market
Forecast, 2021 - 2029
8.2.2.5.4. Middle East and Africa
8.2.2.5.4.1. Market
Estimation, 2020
8.2.2.5.4.2. Market
Forecast, 2021 - 2029
8.2.2.5.5. Latin America
8.2.2.5.5.1. Market
Estimation, 2020
8.2.2.5.5.2. Market
Forecast, 2021 - 2029
8.2.3. Assays and Reagents
8.2.3.1.
Definition
8.2.3.2. Market Estimation and Penetration, 2020
8.2.3.3. Market Forecast, 2021 - 2029
8.2.3.4. Compound Annual Growth Rate (CAGR)
8.2.3.5. Regional Bifurcation
8.2.3.5.1. North America
8.2.3.5.1.1. Market
Estimation, 2020
8.2.3.5.1.2. Market
Forecast, 2021 - 2029
8.2.3.5.2. Europe
8.2.3.5.2.1. Market
Estimation, 2020
8.2.3.5.2.2. Market
Forecast, 2021 - 2029
8.2.3.5.3. Asia Pacific
8.2.3.5.3.1. Market
Estimation, 2020
8.2.3.5.3.2. Market
Forecast, 2021 - 2029
8.2.3.5.4. Middle East and Africa
8.2.3.5.4.1. Market
Estimation, 2020
8.2.3.5.4.2. Market
Forecast, 2021 - 2029
8.2.3.5.5. Latin America
8.2.3.5.5.1. Market
Estimation, 2020
8.2.3.5.5.2. Market
Forecast, 2021 - 2029
8.2.4. Others
8.2.4.1.
Definition
8.2.4.2. Market Estimation and Penetration, 2020
8.2.4.3. Market Forecast, 2021 - 2029
8.2.4.4. Compound Annual Growth Rate (CAGR)
8.2.4.5. Regional Bifurcation
8.2.4.5.1. North America
8.2.4.5.1.1. Market
Estimation, 2020
8.2.4.5.1.2. Market
Forecast, 2021 - 2029
8.2.4.5.2. Europe
8.2.4.5.2.1. Market
Estimation, 2020
8.2.4.5.2.2. Market
Forecast, 2021 - 2029
8.2.4.5.3. Asia Pacific
8.2.4.5.3.1. Market
Estimation, 2020
8.2.4.5.3.2. Market
Forecast, 2021 - 2029
8.2.4.5.4. Middle East and Africa
8.2.4.5.4.1. Market
Estimation, 2020
8.2.4.5.4.2. Market
Forecast, 2021 - 2029
8.2.4.5.5. Latin America
8.2.4.5.5.1. Market
Estimation, 2020
8.2.4.5.5.2. Market
Forecast, 2021 - 2029
8.3. Key Segment for Channeling Investments
8.3.1. By Offerings
9. Global Duplex Sequencing Market Analysis and Forecasts, 2021
– 2029
9.1. Overview
9.2. Global Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Application
9.2.1. Genomics
9.2.1.1.
Definition
9.2.1.2. Market Estimation and Penetration, 2020
9.2.1.3. Market Forecast, 2021 - 2029
9.2.1.4. Compound Annual Growth Rate (CAGR)
9.2.1.5. Regional Bifurcation
9.2.1.5.1. North America
9.2.1.5.1.1. Market
Estimation, 2020
9.2.1.5.1.2. Market
Forecast, 2021 - 2029
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2020
9.2.1.5.2.2. Market
Forecast, 2021 - 2029
9.2.1.5.3. Asia Pacific
9.2.1.5.3.1. Market
Estimation, 2020
9.2.1.5.3.2. Market
Forecast, 2021 - 2029
9.2.1.5.4. Middle East and Africa
9.2.1.5.4.1. Market
Estimation, 2020
9.2.1.5.4.2. Market
Forecast, 2021 - 2029
9.2.1.5.5. Latin America
9.2.1.5.5.1. Market
Estimation, 2020
9.2.1.5.5.2. Market
Forecast, 2021 - 2029
9.2.2. Cancer Research
9.2.2.1.
Definition
9.2.2.2. Market Estimation and Penetration, 2020
9.2.2.3. Market Forecast, 2021 - 2029
9.2.2.4. Compound Annual Growth Rate (CAGR)
9.2.2.5. Regional Bifurcation
9.2.2.5.1. North America
9.2.2.5.1.1. Market
Estimation, 2020
9.2.2.5.1.2. Market
Forecast, 2021 - 2029
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2020
9.2.2.5.2.2. Market
Forecast, 2021 - 2029
9.2.2.5.3. Asia Pacific
9.2.2.5.3.1. Market
Estimation, 2020
9.2.2.5.3.2. Market
Forecast, 2021 - 2029
9.2.2.5.4. Middle East and Africa
9.2.2.5.4.1. Market
Estimation, 2020
9.2.2.5.4.2. Market
Forecast, 2021 - 2029
9.2.2.5.5. Latin America
9.2.2.5.5.1. Market
Estimation, 2020
9.2.2.5.5.2. Market
Forecast, 2021 - 2029
9.2.3. Forensics
9.2.3.1.
Definition
9.2.3.2. Market Estimation and Penetration, 2020
9.2.3.3. Market Forecast, 2021 - 2029
9.2.3.4. Compound Annual Growth Rate (CAGR)
9.2.3.5. Regional Bifurcation
9.2.3.5.1. North America
9.2.3.5.1.1. Market
Estimation, 2020
9.2.3.5.1.2. Market
Forecast, 2021 - 2029
9.2.3.5.2. Europe
9.2.3.5.2.1. Market
Estimation, 2020
9.2.3.5.2.2. Market
Forecast, 2021 - 2029
9.2.3.5.3. Asia Pacific
9.2.3.5.3.1. Market
Estimation, 2020
9.2.3.5.3.2. Market
Forecast, 2021 - 2029
9.2.3.5.4. Middle East and Africa
9.2.3.5.4.1. Market
Estimation, 2020
9.2.3.5.4.2. Market
Forecast, 2021 - 2029
9.2.3.5.5. Latin America
9.2.3.5.5.1. Market
Estimation, 2020
9.2.3.5.5.2. Market
Forecast, 2021 - 2029
9.2.4. Virology
9.2.4.1.
Definition
9.2.4.2. Market Estimation and Penetration, 2020
9.2.4.3. Market Forecast, 2021 - 2029
9.2.4.4. Compound Annual Growth Rate (CAGR)
9.2.4.5. Regional Bifurcation
9.2.4.5.1. North America
9.2.4.5.1.1. Market
Estimation, 2020
9.2.4.5.1.2. Market
Forecast, 2021 - 2029
9.2.4.5.2. Europe
9.2.4.5.2.1. Market
Estimation, 2020
9.2.4.5.2.2. Market
Forecast, 2021 - 2029
9.2.4.5.3. Asia Pacific
9.2.4.5.3.1. Market
Estimation, 2020
9.2.4.5.3.2. Market
Forecast, 2021 - 2029
9.2.4.5.4. Middle East and Africa
9.2.4.5.4.1. Market
Estimation, 2020
9.2.4.5.4.2. Market
Forecast, 2021 - 2029
9.2.4.5.5. Latin America
9.2.4.5.5.1. Market
Estimation, 2020
9.2.4.5.5.2. Market
Forecast, 2021 - 2029
9.2.5. Others
9.2.5.1.
Definition
9.2.5.2. Market Estimation and Penetration, 2020
9.2.5.3. Market Forecast, 2021 - 2029
9.2.5.4. Compound Annual Growth Rate (CAGR)
9.2.5.5. Regional Bifurcation
9.2.5.5.1. North America
9.2.5.5.1.1. Market
Estimation, 2020
9.2.5.5.1.2. Market
Forecast, 2021 - 2029
9.2.5.5.2. Europe
9.2.5.5.2.1. Market
Estimation, 2020
9.2.5.5.2.2. Market
Forecast, 2021 - 2029
9.2.5.5.3. Asia Pacific
9.2.5.5.3.1. Market
Estimation, 2020
9.2.5.5.3.2. Market
Forecast, 2021 - 2029
9.2.5.5.4. Middle East and Africa
9.2.5.5.4.1. Market
Estimation, 2020
9.2.5.5.4.2. Market
Forecast, 2021 - 2029
9.2.5.5.5. Latin America
9.2.5.5.5.1. Market
Estimation, 2020
9.2.5.5.5.2. Market
Forecast, 2021 - 2029
9.3. Key Segment for Channeling Investments
9.3.1. By Application
10. Global Duplex Sequencing Market Analysis and Forecasts, 2021
– 2029
10.1. Overview
10.2. Global Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By End-User
10.2.1. Clinics and Laboratories
10.2.1.1.
Definition
10.2.1.2. Market Estimation and Penetration, 2020
10.2.1.3. Market Forecast, 2021 - 2029
10.2.1.4. Compound Annual Growth Rate (CAGR)
10.2.1.5. Regional Bifurcation
10.2.1.5.1. North America
10.2.1.5.1.1. Market
Estimation, 2020
10.2.1.5.1.2. Market
Forecast, 2021 - 2029
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2020
10.2.1.5.2.2. Market
Forecast, 2021 - 2029
10.2.1.5.3. Asia Pacific
10.2.1.5.3.1. Market
Estimation, 2020
10.2.1.5.3.2. Market
Forecast, 2021 - 2029
10.2.1.5.4. Middle East and Africa
10.2.1.5.4.1. Market
Estimation, 2020
10.2.1.5.4.2. Market
Forecast, 2021 - 2029
10.2.1.5.5. Latin America
10.2.1.5.5.1. Market
Estimation, 2020
10.2.1.5.5.2. Market
Forecast, 2021 - 2029
10.2.2. Hospitals
10.2.2.1.
Definition
10.2.2.2. Market Estimation and Penetration, 2020
10.2.2.3. Market Forecast, 2021 - 2029
10.2.2.4. Compound Annual Growth Rate (CAGR)
10.2.2.5. Regional Bifurcation
10.2.2.5.1. North America
10.2.2.5.1.1. Market
Estimation, 2020
10.2.2.5.1.2. Market
Forecast, 2021 - 2029
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2020
10.2.2.5.2.2. Market
Forecast, 2021 - 2029
10.2.2.5.3. Asia Pacific
10.2.2.5.3.1. Market
Estimation, 2020
10.2.2.5.3.2. Market
Forecast, 2021 - 2029
10.2.2.5.4. Middle East and Africa
10.2.2.5.4.1. Market
Estimation, 2020
10.2.2.5.4.2. Market
Forecast, 2021 - 2029
10.2.2.5.5. Latin America
10.2.2.5.5.1. Market
Estimation, 2020
10.2.2.5.5.2. Market
Forecast, 2021 - 2029
10.2.3. Academic Institutions and Research Centers
10.2.3.1.
Definition
10.2.3.2. Market Estimation and Penetration, 2020
10.2.3.3. Market Forecast, 2021 - 2029
10.2.3.4. Compound Annual Growth Rate (CAGR)
10.2.3.5. Regional Bifurcation
10.2.3.5.1. North America
10.2.3.5.1.1. Market
Estimation, 2020
10.2.3.5.1.2. Market
Forecast, 2021 - 2029
10.2.3.5.2. Europe
10.2.3.5.2.1. Market
Estimation, 2020
10.2.3.5.2.2. Market
Forecast, 2021 - 2029
10.2.3.5.3. Asia Pacific
10.2.3.5.3.1. Market
Estimation, 2020
10.2.3.5.3.2. Market
Forecast, 2021 - 2029
10.2.3.5.4. Middle East and Africa
10.2.3.5.4.1. Market
Estimation, 2020
10.2.3.5.4.2. Market
Forecast, 2021 - 2029
10.2.3.5.5. Latin America
10.2.3.5.5.1. Market
Estimation, 2020
10.2.3.5.5.2. Market
Forecast, 2021 - 2029
10.2.4. Government Forensic Departments
10.2.4.1.
Definition
10.2.4.2. Market Estimation and Penetration, 2020
10.2.4.3. Market Forecast, 2021 - 2029
10.2.4.4. Compound Annual Growth Rate (CAGR)
10.2.4.5. Regional Bifurcation
10.2.4.5.1. North America
10.2.4.5.1.1. Market
Estimation, 2020
10.2.4.5.1.2. Market
Forecast, 2021 - 2029
10.2.4.5.2. Europe
10.2.4.5.2.1. Market
Estimation, 2020
10.2.4.5.2.2. Market
Forecast, 2021 - 2029
10.2.4.5.3. Asia Pacific
10.2.4.5.3.1. Market
Estimation, 2020
10.2.4.5.3.2. Market
Forecast, 2021 - 2029
10.2.4.5.4. Middle East and Africa
10.2.4.5.4.1. Market
Estimation, 2020
10.2.4.5.4.2. Market
Forecast, 2021 - 2029
10.2.4.5.5. Latin America
10.2.4.5.5.1. Market
Estimation, 2020
10.2.4.5.5.2. Market
Forecast, 2021 - 2029
10.2.5. Others
10.2.5.1.
Definition
10.2.5.2. Market Estimation and Penetration, 2020
10.2.5.3. Market Forecast, 2021 - 2029
10.2.5.4. Compound Annual Growth Rate (CAGR)
10.2.5.5. Regional Bifurcation
10.2.5.5.1. North America
10.2.5.5.1.1. Market
Estimation, 2020
10.2.5.5.1.2. Market
Forecast, 2021 - 2029
10.2.5.5.2. Europe
10.2.5.5.2.1. Market
Estimation, 2020
10.2.5.5.2.2. Market
Forecast, 2021 - 2029
10.2.5.5.3. Asia Pacific
10.2.5.5.3.1. Market
Estimation, 2020
10.2.5.5.3.2. Market
Forecast, 2021 - 2029
10.2.5.5.4. Middle East and Africa
10.2.5.5.4.1. Market
Estimation, 2020
10.2.5.5.4.2. Market
Forecast, 2021 - 2029
10.2.5.5.5. Latin America
10.2.5.5.5.1. Market
Estimation, 2020
10.2.5.5.5.2. Market
Forecast, 2021 - 2029
10.3. Key Segment for Channeling Investments
10.3.1. By End-User
11. North America Duplex Sequencing Market Analysis and
Forecasts, 2021 - 2029
11.1. Overview
11.1.1. North America Duplex Sequencing Market Revenue (US$ Mn)
11.2. North America Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Offerings
11.2.1. Software and Tools
11.2.2. Duplex Sequencing Kits
11.2.3. Assays and Reagents
11.2.4. Others
11.3. North America Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Application
11.3.1. Genomics
11.3.2. Cancer Research
11.3.3. Forensics
11.3.4. Virology
11.3.5. Others
11.4. North America Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By End-User
11.4.1. Clinics and Laboratories
11.4.2. Hospitals
11.4.3. Academic Institutions and Research Centers
11.4.4. Government Forensic Departments
11.4.5. Others
11.5. North America Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Country
11.5.1. U.S
11.5.1.1. U.S Duplex Sequencing Market Revenue (US$ Mn) and Forecasts,
By Offerings
11.5.1.1.1. Software and Tools
11.5.1.1.2. Duplex Sequencing Kits
11.5.1.1.3. Assays and Reagents
11.5.1.1.4. Others
11.5.1.2. U.S Duplex Sequencing Market Revenue (US$ Mn) and Forecasts,
By Application
11.5.1.2.1. Genomics
11.5.1.2.2. Cancer Research
11.5.1.2.3. Forensics
11.5.1.2.4. Virology
11.5.1.2.5. Others
11.5.1.3. U.S Duplex Sequencing Market Revenue (US$ Mn) and Forecasts,
By End-User
11.5.1.3.1. Clinics and Laboratories
11.5.1.3.2. Hospitals
11.5.1.3.3. Academic Institutions and Research Centers
11.5.1.3.4. Government Forensic Departments
11.5.1.3.5. Others
11.5.2. Canada
11.5.2.1. Canada Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Offerings
11.5.2.1.1. Software and Tools
11.5.2.1.2. Duplex Sequencing Kits
11.5.2.1.3. Assays and Reagents
11.5.2.1.4. Others
11.5.2.2. Canada Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Application
11.5.2.2.1. Genomics
11.5.2.2.2. Cancer Research
11.5.2.2.3. Forensics
11.5.2.2.4. Virology
11.5.2.2.5. Others
11.5.2.3. Canada Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By End-User
11.5.2.3.1. Clinics and Laboratories
11.5.2.3.2. Hospitals
11.5.2.3.3. Academic Institutions and Research Centers
11.5.2.3.4. Government Forensic Departments
11.5.2.3.5. Others
11.5.3. Mexico
11.5.3.1. Mexico Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Offerings
11.5.3.1.1. Software and Tools
11.5.3.1.2. Duplex Sequencing Kits
11.5.3.1.3. Assays and Reagents
11.5.3.1.4. Others
11.5.3.2. Mexico Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Application
11.5.3.2.1. Genomics
11.5.3.2.2. Cancer Research
11.5.3.2.3. Forensics
11.5.3.2.4. Virology
11.5.3.2.5. Others
11.5.3.3. Mexico Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By End-User
11.5.3.3.1. Clinics and Laboratories
11.5.3.3.2. Hospitals
11.5.3.3.3. Academic Institutions and Research Centers
11.5.3.3.4. Government Forensic Departments
11.5.3.3.5. Others
11.5.4. Rest of North America
11.5.4.1. Rest of North America Duplex Sequencing Market Revenue (US$
Mn) and Forecasts, By Offerings
11.5.4.1.1. Software and Tools
11.5.4.1.2. Duplex Sequencing Kits
11.5.4.1.3. Assays and Reagents
11.5.4.1.4. Others
11.5.4.2. Rest of North America Duplex Sequencing Market Revenue (US$
Mn) and Forecasts, By Application
11.5.4.2.1. Genomics
11.5.4.2.2. Cancer Research
11.5.4.2.3. Forensics
11.5.4.2.4. Virology
11.5.4.2.5. Others
11.5.4.3. Rest of North America Duplex Sequencing Market Revenue (US$
Mn) and Forecasts, By End-User
11.5.4.3.1. Clinics and Laboratories
11.5.4.3.2. Hospitals
11.5.4.3.3. Academic Institutions and Research Centers
11.5.4.3.4. Government Forensic Departments
11.5.4.3.5. Others
11.6. Key Segment for Channeling Investments
11.6.1. By Country
11.6.2. By Offerings
11.6.3. By Application
11.6.4. By End-User
12. Europe Duplex Sequencing Market Analysis and Forecasts, 2021
- 2029
12.1. Overview
12.1.1. Europe Duplex Sequencing Market Revenue (US$ Mn)
12.2. Europe Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Offerings
12.2.1. Software and Tools
12.2.2. Duplex Sequencing Kits
12.2.3. Assays and Reagents
12.2.4. Others
12.3. Europe Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Application
12.3.1. Genomics
12.3.2. Cancer Research
12.3.3. Forensics
12.3.4. Virology
12.3.5. Others
12.4. Europe Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By End-User
12.4.1. Clinics and Laboratories
12.4.2. Hospitals
12.4.3. Academic Institutions and Research Centers
12.4.4. Government Forensic Departments
12.4.5. Others
12.5. Europe Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Country
12.5.1. France
12.5.1.1. France Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Offerings
12.5.1.1.1. Software and Tools
12.5.1.1.2. Duplex Sequencing Kits
12.5.1.1.3. Assays and Reagents
12.5.1.1.4. Others
12.5.1.2. France Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Application
12.5.1.2.1. Genomics
12.5.1.2.2. Cancer Research
12.5.1.2.3. Forensics
12.5.1.2.4. Virology
12.5.1.2.5. Others
12.5.1.3. France Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By End-User
12.5.1.3.1. Clinics and Laboratories
12.5.1.3.2. Hospitals
12.5.1.3.3. Academic Institutions and Research Centers
12.5.1.3.4. Government Forensic Departments
12.5.1.3.5. Others
12.5.2. The UK
12.5.2.1. The UK Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Offerings
12.5.2.1.1. Software and Tools
12.5.2.1.2. Duplex Sequencing Kits
12.5.2.1.3. Assays and Reagents
12.5.2.1.4. Others
12.5.2.2. The UK Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Application
12.5.2.2.1. Genomics
12.5.2.2.2. Cancer Research
12.5.2.2.3. Forensics
12.5.2.2.4. Virology
12.5.2.2.5. Others
12.5.2.3. The UK Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By End-User
12.5.2.3.1. Clinics and Laboratories
12.5.2.3.2. Hospitals
12.5.2.3.3. Academic Institutions and Research Centers
12.5.2.3.4. Government Forensic Departments
12.5.2.3.5. Others
12.5.3. Spain
12.5.3.1. Spain Duplex Sequencing Market Revenue (US$ Mn) and Forecasts,
By Offerings
12.5.3.1.1. Software and Tools
12.5.3.1.2. Duplex Sequencing Kits
12.5.3.1.3. Assays and Reagents
12.5.3.1.4. Others
12.5.3.2. Spain Duplex Sequencing Market Revenue (US$ Mn) and Forecasts,
By Application
12.5.3.2.1. Genomics
12.5.3.2.2. Cancer Research
12.5.3.2.3. Forensics
12.5.3.2.4. Virology
12.5.3.2.5. Others
12.5.3.3. Spain Duplex Sequencing Market Revenue (US$ Mn) and Forecasts,
By End-User
12.5.3.3.1. Clinics and Laboratories
12.5.3.3.2. Hospitals
12.5.3.3.3. Academic Institutions and Research Centers
12.5.3.3.4. Government Forensic Departments
12.5.3.3.5. Others
12.5.4. Germany
12.5.4.1. Germany Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Offerings
12.5.4.1.1. Software and Tools
12.5.4.1.2. Duplex Sequencing Kits
12.5.4.1.3. Assays and Reagents
12.5.4.1.4. Others
12.5.4.2. Germany Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Application
12.5.4.2.1. Genomics
12.5.4.2.2. Cancer Research
12.5.4.2.3. Forensics
12.5.4.2.4. Virology
12.5.4.2.5. Others
12.5.4.3. Germany Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By End-User
12.5.4.3.1. Clinics and Laboratories
12.5.4.3.2. Hospitals
12.5.4.3.3. Academic Institutions and Research Centers
12.5.4.3.4. Government Forensic Departments
12.5.4.3.5. Others
12.5.5. Italy
12.5.5.1. Italy Duplex Sequencing Market Revenue (US$ Mn) and Forecasts,
By Offerings
12.5.5.1.1. Software and Tools
12.5.5.1.2. Duplex Sequencing Kits
12.5.5.1.3. Assays and Reagents
12.5.5.1.4. Others
12.5.5.2. Italy Duplex Sequencing Market Revenue (US$ Mn) and Forecasts,
By Application
12.5.5.2.1. Genomics
12.5.5.2.2. Cancer Research
12.5.5.2.3. Forensics
12.5.5.2.4. Virology
12.5.5.2.5. Others
12.5.5.3. Italy Duplex Sequencing Market Revenue (US$ Mn) and Forecasts,
By End-User
12.5.5.3.1. Clinics and Laboratories
12.5.5.3.2. Hospitals
12.5.5.3.3. Academic Institutions and Research Centers
12.5.5.3.4. Government Forensic Departments
12.5.5.3.5. Others
12.5.6. Nordic Countries
12.5.6.1. Nordic Countries Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Offerings
12.5.6.1.1. Software and Tools
12.5.6.1.2. Duplex Sequencing Kits
12.5.6.1.3. Assays and Reagents
12.5.6.1.4. Others
12.5.6.2. Nordic Countries Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Application
12.5.6.2.1. Genomics
12.5.6.2.2. Cancer Research
12.5.6.2.3. Forensics
12.5.6.2.4. Virology
12.5.6.2.5. Others
12.5.6.3. Nordic Countries Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By End-User
12.5.6.3.1. Clinics and Laboratories
12.5.6.3.2. Hospitals
12.5.6.3.3. Academic Institutions and Research Centers
12.5.6.3.4. Government Forensic Departments
12.5.6.3.5. Others
12.5.6.4. Nordic Countries Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Country
12.5.6.4.1. Denmark
12.5.6.4.2. Finland
12.5.6.4.3. Iceland
12.5.6.4.4. Sweden
12.5.6.4.5. Norway
12.5.7. Benelux Union
12.5.7.1. Benelux Union Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Offerings
12.5.7.1.1. Software and Tools
12.5.7.1.2. Duplex Sequencing Kits
12.5.7.1.3. Assays and Reagents
12.5.7.1.4. Others
12.5.7.2. Benelux Union Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Application
12.5.7.2.1. Genomics
12.5.7.2.2. Cancer Research
12.5.7.2.3. Forensics
12.5.7.2.4. Virology
12.5.7.2.5. Others
12.5.7.3. Benelux Union Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By End-User
12.5.7.3.1. Clinics and Laboratories
12.5.7.3.2. Hospitals
12.5.7.3.3. Academic Institutions and Research Centers
12.5.7.3.4. Government Forensic Departments
12.5.7.3.5. Others
12.5.7.4. Benelux Union Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Country
12.5.7.4.1. Belgium
12.5.7.4.2. The Netherlands
12.5.7.4.3. Luxembourg
12.5.8. Rest of Europe
12.5.8.1. Rest of Europe Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Offerings
12.5.8.1.1. Software and Tools
12.5.8.1.2. Duplex Sequencing Kits
12.5.8.1.3. Assays and Reagents
12.5.8.1.4. Others
12.5.8.2. Rest of Europe Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Application
12.5.8.2.1. Genomics
12.5.8.2.2. Cancer Research
12.5.8.2.3. Forensics
12.5.8.2.4. Virology
12.5.8.2.5. Others
12.5.8.3. Rest of Europe Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By End-User
12.5.8.3.1. Clinics and Laboratories
12.5.8.3.2. Hospitals
12.5.8.3.3. Academic Institutions and Research Centers
12.5.8.3.4. Government Forensic Departments
12.5.8.3.5. Others
12.6. Key Segment for Channeling Investments
12.6.1. By Country
12.6.2. By Offerings
12.6.3. By Application
12.6.4. By End-User
13. Asia Pacific Duplex Sequencing Market Analysis and Forecasts,
2021 - 2029
13.1. Overview
13.1.1. Asia Pacific Duplex Sequencing Market Revenue (US$ Mn)
13.2. Asia Pacific Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Offerings
13.2.1. Software and Tools
13.2.2. Duplex Sequencing Kits
13.2.3. Assays and Reagents
13.2.4. Others
13.3. Asia Pacific Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Application
13.3.1. Genomics
13.3.2. Cancer Research
13.3.3. Forensics
13.3.4. Virology
13.3.5. Others
13.4. Asia Pacific Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By End-User
13.4.1. Clinics and Laboratories
13.4.2. Hospitals
13.4.3. Academic Institutions and Research Centers
13.4.4. Government Forensic Departments
13.4.5. Others
13.5. Asia Pacific Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Country
13.5.1. China
13.5.1.1. China Duplex Sequencing Market Revenue (US$ Mn) and Forecasts,
By Offerings
13.5.1.1.1. Software and Tools
13.5.1.1.2. Duplex Sequencing Kits
13.5.1.1.3. Assays and Reagents
13.5.1.1.4. Others
13.5.1.2. China Duplex Sequencing Market Revenue (US$ Mn) and Forecasts,
By Application
13.5.1.2.1. Genomics
13.5.1.2.2. Cancer Research
13.5.1.2.3. Forensics
13.5.1.2.4. Virology
13.5.1.2.5. Others
13.5.1.3. China Duplex Sequencing Market Revenue (US$ Mn) and Forecasts,
By End-User
13.5.1.3.1. Clinics and Laboratories
13.5.1.3.2. Hospitals
13.5.1.3.3. Academic Institutions and Research Centers
13.5.1.3.4. Government Forensic Departments
13.5.1.3.5. Others
13.5.2. Japan
13.5.2.1. Japan Duplex Sequencing Market Revenue (US$ Mn) and Forecasts,
By Offerings
13.5.2.1.1. Software and Tools
13.5.2.1.2. Duplex Sequencing Kits
13.5.2.1.3. Assays and Reagents
13.5.2.1.4. Others
13.5.2.2. Japan Duplex Sequencing Market Revenue (US$ Mn) and Forecasts,
By Application
13.5.2.2.1. Genomics
13.5.2.2.2. Cancer Research
13.5.2.2.3. Forensics
13.5.2.2.4. Virology
13.5.2.2.5. Others
13.5.2.3. Japan Duplex Sequencing Market Revenue (US$ Mn) and Forecasts,
By End-User
13.5.2.3.1. Clinics and Laboratories
13.5.2.3.2. Hospitals
13.5.2.3.3. Academic Institutions and Research Centers
13.5.2.3.4. Government Forensic Departments
13.5.2.3.5. Others
13.5.3. India
13.5.3.1. India Duplex Sequencing Market Revenue (US$ Mn) and Forecasts,
By Offerings
13.5.3.1.1. Software and Tools
13.5.3.1.2. Duplex Sequencing Kits
13.5.3.1.3. Assays and Reagents
13.5.3.1.4. Others
13.5.3.2. India Duplex Sequencing Market Revenue (US$ Mn) and Forecasts,
By Application
13.5.3.2.1. Genomics
13.5.3.2.2. Cancer Research
13.5.3.2.3. Forensics
13.5.3.2.4. Virology
13.5.3.2.5. Others
13.5.3.3. India Duplex Sequencing Market Revenue (US$ Mn) and Forecasts,
By End-User
13.5.3.3.1. Clinics and Laboratories
13.5.3.3.2. Hospitals
13.5.3.3.3. Academic Institutions and Research Centers
13.5.3.3.4. Government Forensic Departments
13.5.3.3.5. Others
13.5.4. New Zealand
13.5.4.1. New Zealand Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Offerings
13.5.4.1.1. Software and Tools
13.5.4.1.2. Duplex Sequencing Kits
13.5.4.1.3. Assays and Reagents
13.5.4.1.4. Others
13.5.4.2. New Zealand Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Application
13.5.4.2.1. Genomics
13.5.4.2.2. Cancer Research
13.5.4.2.3. Forensics
13.5.4.2.4. Virology
13.5.4.2.5. Others
13.5.4.3. New Zealand Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By End-User
13.5.4.3.1. Clinics and Laboratories
13.5.4.3.2. Hospitals
13.5.4.3.3. Academic Institutions and Research Centers
13.5.4.3.4. Government Forensic Departments
13.5.4.3.5. Others
13.5.5. Australia
13.5.5.1. Australia Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Offerings
13.5.5.1.1. Software and Tools
13.5.5.1.2. Duplex Sequencing Kits
13.5.5.1.3. Assays and Reagents
13.5.5.1.4. Others
13.5.5.2. Australia Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Application
13.5.5.2.1. Genomics
13.5.5.2.2. Cancer Research
13.5.5.2.3. Forensics
13.5.5.2.4. Virology
13.5.5.2.5. Others
13.5.5.3. Australia Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By End-User
13.5.5.3.1. Clinics and Laboratories
13.5.5.3.2. Hospitals
13.5.5.3.3. Academic Institutions and Research Centers
13.5.5.3.4. Government Forensic Departments
13.5.5.3.5. Others
13.5.6. South Korea
13.5.6.1. South Korea Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Offerings
13.5.6.1.1. Software and Tools
13.5.6.1.2. Duplex Sequencing Kits
13.5.6.1.3. Assays and Reagents
13.5.6.1.4. Others
13.5.6.2. South Korea Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Application
13.5.6.2.1. Genomics
13.5.6.2.2. Cancer Research
13.5.6.2.3. Forensics
13.5.6.2.4. Virology
13.5.6.2.5. Others
13.5.6.3. South Korea Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By End-User
13.5.6.3.1. Clinics and Laboratories
13.5.6.3.2. Hospitals
13.5.6.3.3. Academic Institutions and Research Centers
13.5.6.3.4. Government Forensic Departments
13.5.6.3.5. Others
13.5.7. Southeast Asia
13.5.7.1. Southeast Asia Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Offerings
13.5.7.1.1. Software and Tools
13.5.7.1.2. Duplex Sequencing Kits
13.5.7.1.3. Assays and Reagents
13.5.7.1.4. Others
13.5.7.2. Southeast Asia Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Application
13.5.7.2.1. Genomics
13.5.7.2.2. Cancer Research
13.5.7.2.3. Forensics
13.5.7.2.4. Virology
13.5.7.2.5. Others
13.5.7.3. Southeast Asia Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By End-User
13.5.7.3.1. Clinics and Laboratories
13.5.7.3.2. Hospitals
13.5.7.3.3. Academic Institutions and Research Centers
13.5.7.3.4. Government Forensic Departments
13.5.7.3.5. Others
13.5.7.4. Southeast Asia Duplex Sequencing Market Revenue (US$ Mn) and Forecasts,
By Country
13.5.7.4.1. Indonesia
13.5.7.4.2. Thailand
13.5.7.4.3. Malaysia
13.5.7.4.4. Singapore
13.5.7.4.5. Rest of Southeast Asia
13.5.8. Rest of Asia Pacific
13.5.8.1. Rest of Asia Pacific Duplex Sequencing Market Revenue (US$ Mn)
and Forecasts, By Offerings
13.5.8.1.1. Software and Tools
13.5.8.1.2. Duplex Sequencing Kits
13.5.8.1.3. Assays and Reagents
13.5.8.1.4. Others
13.5.8.2. Rest of Asia Pacific Duplex Sequencing Market Revenue (US$ Mn)
and Forecasts, By Application
13.5.8.2.1. Genomics
13.5.8.2.2. Cancer Research
13.5.8.2.3. Forensics
13.5.8.2.4. Virology
13.5.8.2.5. Others
13.5.8.3. Rest of Asia Pacific Duplex Sequencing Market Revenue (US$ Mn)
and Forecasts, By End-User
13.5.8.3.1. Clinics and Laboratories
13.5.8.3.2. Hospitals
13.5.8.3.3. Academic Institutions and Research Centers
13.5.8.3.4. Government Forensic Departments
13.5.8.3.5. Others
13.6. Key Segment for Channeling Investments
13.6.1. By Country
13.6.2. By Offerings
13.6.3. By Application
13.6.4. By End-User
14. Middle East and Africa Duplex Sequencing Market Analysis and Forecasts,
2021 - 2029
14.1. Overview
14.1.1. Middle East and Africa Duplex Sequencing Market Revenue (US$
Mn)
14.2. Middle East and Africa Duplex Sequencing Market Revenue (US$
Mn) and Forecasts, By Offerings
14.2.1. Software and Tools
14.2.2. Duplex Sequencing Kits
14.2.3. Assays and Reagents
14.2.4. Others
14.3. Middle East and Africa Duplex Sequencing Market Revenue (US$
Mn) and Forecasts, By Application
14.3.1. Genomics
14.3.2. Cancer Research
14.3.3. Forensics
14.3.4. Virology
14.3.5. Others
14.4. Middle East and Africa Duplex Sequencing Market Revenue (US$
Mn) and Forecasts, By End-User
14.4.1. Clinics and Laboratories
14.4.2. Hospitals
14.4.3. Academic Institutions and Research Centers
14.4.4. Government Forensic Departments
14.4.5. Others
14.5. Middle East and Africa Duplex Sequencing Market Revenue (US$
Mn) and Forecasts, By Country
14.5.1. Saudi Arabia
14.5.1.1. Saudi Arabia Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Offerings
14.5.1.1.1. Software and Tools
14.5.1.1.2. Duplex Sequencing Kits
14.5.1.1.3. Assays and Reagents
14.5.1.1.4. Others
14.5.1.2. Saudi Arabia Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Application
14.5.1.2.1. Genomics
14.5.1.2.2. Cancer Research
14.5.1.2.3. Forensics
14.5.1.2.4. Virology
14.5.1.2.5. Others
14.5.1.3. Saudi Arabia Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By End-User
14.5.1.3.1. Clinics and Laboratories
14.5.1.3.2. Hospitals
14.5.1.3.3. Academic Institutions and Research Centers
14.5.1.3.4. Government Forensic Departments
14.5.1.3.5. Others
14.5.2. UAE
14.5.2.1. UAE Duplex Sequencing Market Revenue (US$ Mn) and Forecasts,
By Offerings
14.5.2.1.1. Software and Tools
14.5.2.1.2. Duplex Sequencing Kits
14.5.2.1.3. Assays and Reagents
14.5.2.1.4. Others
14.5.2.2. UAE Duplex Sequencing Market Revenue (US$ Mn) and Forecasts,
By Application
14.5.2.2.1. Genomics
14.5.2.2.2. Cancer Research
14.5.2.2.3. Forensics
14.5.2.2.4. Virology
14.5.2.2.5. Others
14.5.2.3. UAE Duplex Sequencing Market Revenue (US$ Mn) and Forecasts,
By End-User
14.5.2.3.1. Clinics and Laboratories
14.5.2.3.2. Hospitals
14.5.2.3.3. Academic Institutions and Research Centers
14.5.2.3.4. Government Forensic Departments
14.5.2.3.5. Others
14.5.3. Egypt
14.5.3.1. Egypt Duplex Sequencing Market Revenue (US$ Mn) and Forecasts,
By Offerings
14.5.3.1.1. Software and Tools
14.5.3.1.2. Duplex Sequencing Kits
14.5.3.1.3. Assays and Reagents
14.5.3.1.4. Others
14.5.3.2. Egypt Duplex Sequencing Market Revenue (US$ Mn) and Forecasts,
By Application
14.5.3.2.1. Genomics
14.5.3.2.2. Cancer Research
14.5.3.2.3. Forensics
14.5.3.2.4. Virology
14.5.3.2.5. Others
14.5.3.3. Egypt Duplex Sequencing Market Revenue (US$ Mn) and Forecasts,
By End-User
14.5.3.3.1. Clinics and Laboratories
14.5.3.3.2. Hospitals
14.5.3.3.3. Academic Institutions and Research Centers
14.5.3.3.4. Government Forensic Departments
14.5.3.3.5. Others
14.5.4. Kuwait
14.5.4.1. Kuwait Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Offerings
14.5.4.1.1. Software and Tools
14.5.4.1.2. Duplex Sequencing Kits
14.5.4.1.3. Assays and Reagents
14.5.4.1.4. Others
14.5.4.2. Kuwait Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Application
14.5.4.2.1. Genomics
14.5.4.2.2. Cancer Research
14.5.4.2.3. Forensics
14.5.4.2.4. Virology
14.5.4.2.5. Others
14.5.4.3. Kuwait Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By End-User
14.5.4.3.1. Clinics and Laboratories
14.5.4.3.2. Hospitals
14.5.4.3.3. Academic Institutions and Research Centers
14.5.4.3.4. Government Forensic Departments
14.5.4.3.5. Others
14.5.5. South Africa
14.5.5.1. South Africa Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Offerings
14.5.5.1.1. Software and Tools
14.5.5.1.2. Duplex Sequencing Kits
14.5.5.1.3. Assays and Reagents
14.5.5.1.4. Others
14.5.5.2. South Africa Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Application
14.5.5.2.1. Genomics
14.5.5.2.2. Cancer Research
14.5.5.2.3. Forensics
14.5.5.2.4. Virology
14.5.5.2.5. Others
14.5.5.3. South Africa Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By End-User
14.5.5.3.1. Clinics and Laboratories
14.5.5.3.2. Hospitals
14.5.5.3.3. Academic Institutions and Research Centers
14.5.5.3.4. Government Forensic Departments
14.5.5.3.5. Others
14.5.6. Rest of Middle East & Africa
14.5.6.1. Rest of Middle East & Africa Duplex Sequencing Market
Revenue (US$ Mn) and Forecasts, By Offerings
14.5.6.1.1. Software and Tools
14.5.6.1.2. Duplex Sequencing Kits
14.5.6.1.3. Assays and Reagents
14.5.6.1.4. Others
14.5.6.2. Rest of Middle East & Africa Duplex Sequencing Market
Revenue (US$ Mn) and Forecasts, By Application
14.5.6.2.1. Genomics
14.5.6.2.2. Cancer Research
14.5.6.2.3. Forensics
14.5.6.2.4. Virology
14.5.6.2.5. Others
14.5.6.3. Rest of Middle East & Africa Duplex Sequencing Market
Revenue (US$ Mn) and Forecasts, By End-User
14.5.6.3.1. Clinics and Laboratories
14.5.6.3.2. Hospitals
14.5.6.3.3. Academic Institutions and Research Centers
14.5.6.3.4. Government Forensic Departments
14.5.6.3.5. Others
14.6. Key Segment for Channeling Investments
14.6.1. By Country
14.6.2. By Offerings
14.6.3. By Application
14.6.4. By End-User
15. Latin America Duplex Sequencing Market Analysis and Forecasts,
2021 - 2029
15.1. Overview
15.1.1. Latin America Duplex Sequencing Market Revenue (US$ Mn)
15.2. Latin America Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Offerings
15.2.1. Software and Tools
15.2.2. Duplex Sequencing Kits
15.2.3. Assays and Reagents
15.2.4. Others
15.3. Latin America Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Application
15.3.1. Genomics
15.3.2. Cancer Research
15.3.3. Forensics
15.3.4. Virology
15.3.5. Others
15.4. Latin America Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By End-User
15.4.1. Clinics and Laboratories
15.4.2. Hospitals
15.4.3. Academic Institutions and Research Centers
15.4.4. Government Forensic Departments
15.4.5. Others
15.5. Latin America Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Country
15.5.1. Brazil
15.5.1.1. Brazil Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Offerings
15.5.1.1.1. Software and Tools
15.5.1.1.2. Duplex Sequencing Kits
15.5.1.1.3. Assays and Reagents
15.5.1.1.4. Others
15.5.1.2. Brazil Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Application
15.5.1.2.1. Genomics
15.5.1.2.2. Cancer Research
15.5.1.2.3. Forensics
15.5.1.2.4. Virology
15.5.1.2.5. Others
15.5.1.3. Brazil Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By End-User
15.5.1.3.1. Clinics and Laboratories
15.5.1.3.2. Hospitals
15.5.1.3.3. Academic Institutions and Research Centers
15.5.1.3.4. Government Forensic Departments
15.5.1.3.5. Others
15.5.2. Argentina
15.5.2.1. Argentina Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Offerings
15.5.2.1.1. Software and Tools
15.5.2.1.2. Duplex Sequencing Kits
15.5.2.1.3. Assays and Reagents
15.5.2.1.4. Others
15.5.2.2. Argentina Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By Application
15.5.2.2.1. Genomics
15.5.2.2.2. Cancer Research
15.5.2.2.3. Forensics
15.5.2.2.4. Virology
15.5.2.2.5. Others
15.5.2.3. Argentina Duplex Sequencing Market Revenue (US$ Mn) and
Forecasts, By End-User
15.5.2.3.1. Clinics and Laboratories
15.5.2.3.2. Hospitals
15.5.2.3.3. Academic Institutions and Research Centers
15.5.2.3.4. Government Forensic Departments
15.5.2.3.5. Others
15.5.3. Rest of Latin America
15.5.3.1. Rest of Latin America Duplex Sequencing Market Revenue (US$
Mn) and Forecasts, By Offerings
15.5.3.1.1. Software and Tools
15.5.3.1.2. Duplex Sequencing Kits
15.5.3.1.3. Assays and Reagents
15.5.3.1.4. Others
15.5.3.2. Rest of Latin America Duplex Sequencing Market Revenue (US$
Mn) and Forecasts, By Application
15.5.3.2.1. Genomics
15.5.3.2.2. Cancer Research
15.5.3.2.3. Forensics
15.5.3.2.4. Virology
15.5.3.2.5. Others
15.5.3.3. Rest of Latin America Duplex Sequencing Market Revenue (US$
Mn) and Forecasts, By End-User
15.5.3.3.1. Clinics and Laboratories
15.5.3.3.2. Hospitals
15.5.3.3.3. Academic Institutions and Research Centers
15.5.3.3.4. Government Forensic Departments
15.5.3.3.5. Others
15.6. Key Segment for Channeling Investments
15.6.1. By Country
15.6.2. By Offerings
15.6.3. By Application
15.6.4. By End-User
16. Competitive Benchmarking
16.1. Player Positioning Analysis
16.2. Global Presence and Growth Strategies
16.2.1. Mergers and Acquisitions
16.2.2. Product Launches
16.2.3. Investments Trends
16.2.4. R&D Initiatives
17. Player Profiles
17.1. ATDBio Ltd.
17.1.1. Company Details
17.1.2. Company Overview
17.1.3. Product Offerings
17.1.4. Key Developments
17.1.5. Financial Analysis
17.1.6. SWOT Analysis
17.1.7. Business Strategies
17.2. Illumina, Inc.
17.2.1. Company Details
17.2.2. Company Overview
17.2.3. Product Offerings
17.2.4. Key Developments
17.2.5. Financial Analysis
17.2.6. SWOT Analysis
17.2.7. Business Strategies
17.3. Promega Corporation
17.3.1. Company Details
17.3.2. Company Overview
17.3.3. Product Offerings
17.3.4. Key Developments
17.3.5. Financial Analysis
17.3.6. SWOT Analysis
17.3.7. Business Strategies
17.4. QIAGEN
17.4.1. Company Details
17.4.2. Company Overview
17.4.3. Product Offerings
17.4.4. Key Developments
17.4.5. Financial Analysis
17.4.6. SWOT Analysis
17.4.7. Business Strategies
17.5. Thermo Fisher Scientific
17.5.1. Company Details
17.5.2. Company Overview
17.5.3. Product Offerings
17.5.4. Key Developments
17.5.5. Financial Analysis
17.5.6. SWOT Analysis
17.5.7. Business Strategies
17.6. TwinStrand Biosciences, Inc.
17.6.1. Company Details
17.6.2. Company Overview
17.6.3. Product Offerings
17.6.4. Key Developments
17.6.5. Financial Analysis
17.6.6. SWOT Analysis
17.6.7. Business Strategies
17.7. Other Market Participants
18. Key Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User
and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.